GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CCNE · Dec 31, 2022

CNB FINANCIAL CORP/PA. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000736772-23-000023Bank
Sequential deposit growth15thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.03% · CORE · VALID

Net-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

9.50% · CORE · VALID

Interest-expense growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_expense

21.49% · CORE · VALID

Interest-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

19.01% · CORE · VALID

Cash and equivalents40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$106.3M · CORE · VALID

Sequential loan growth85thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

6.23% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History51 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-1.66%
Current
-0.03%
Delta
1.63%
Liquidity Decreased
Previous
$209.8M
Current
$106.3M
Delta
-$103.5M
Loan Growth Increased
Previous
2.95%
Current
6.23%
Delta
3.28%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.